Cargando…
Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis
Sarcoidosis is a multisystem granulomatous disease of unknown origin that has variable clinical course and can affect nearly any organ. It has a chronic course in about 25% of patients. Corticosteroids (CS) are the cornerstone of therapy but their long-term use is associated with cumulative toxicity...
Autores principales: | Boleto, Gonçalo, Vieira, Matheus, Desbois, Anne Claire, Saadoun, David, Cacoub, Patrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732552/ https://www.ncbi.nlm.nih.gov/pubmed/33330556 http://dx.doi.org/10.3389/fmed.2020.594133 |
Ejemplares similares
-
Cardiac sarcoidosis: A long term follow up study
por: Cacoub, Patrice, et al.
Publicado: (2020) -
Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021) -
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review
por: Desbois, Anne-Claire, et al.
Publicado: (2017) -
Biotherapies in Uveitis
por: Leclercq, Mathilde, et al.
Publicado: (2020) -
Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study
por: Desbois, Anne Claire, et al.
Publicado: (2016)